Literature DB >> 16198603

Interleukin-6 gene polymorphism and risk of osteoarthritis of the hip: a case-control study.

E Pola1, P Papaleo, R Pola, E Gaetani, F C Tamburelli, L Aulisa, C A Logroscino.   

Abstract

OBJECTIVES: Osteoarthritis (OA) is considered a polygenic disease controlled by the expression of genetic factors. Genes encoding for cytokines have been associated with susceptibility for joint OA and interleukin (IL)-6 gene is also supposed to be involved in the cartilage degradation process. In this case-control study, we evaluated for the first time whether the risk of hip OA might be influenced by the -174 IL-6 gene polymorphism.
METHODS: The distribution of IL-6 genotypes was evaluated in 75 patients affected by hip OA and in 107 age- and sex-matched controls.
RESULTS: The distribution of IL-6 genotypes in (1) patients with hip OA: 33 GG, 30 GC, 12 CC and (2) control subjects: 34 GG, 40 GC, 33 CC. The frequency of the CC genotype was significantly higher in control patients (P=0.02). Logistic regression analysis indicated that the presence of the CC genotype is independently associated with a decreased risk of OA (odds ratio 0.4 [95% confidence interval 0.1-0.9], P=0.04).
CONCLUSIONS: Primary OA of the hip has an important genetic component and variations of genes encoding for inflammatory cytokines, such as IL-6, may play an important role in the series of events responsible for the pathophysiology of OA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16198603     DOI: 10.1016/j.joca.2005.07.011

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  12 in total

Review 1.  Relationship between joint shape and the development of osteoarthritis.

Authors:  Julie C Baker-LePain; Nancy E Lane
Journal:  Curr Opin Rheumatol       Date:  2010-09       Impact factor: 5.006

Review 2.  Epigenetic mechanisms underlying the aberrant catabolic and anabolic activities of osteoarthritic chondrocytes.

Authors:  Mingcai Zhang; Brian Egan; Jinxi Wang
Journal:  Int J Biochem Cell Biol       Date:  2015-05-12       Impact factor: 5.085

3.  Relationships of common polymorphisms in IL-6, IL-1A, and IL-1B genes with susceptibility to osteoarthritis: a meta-analysis.

Authors:  Hao Cai; Huan-Jian Sun; You-Hua Wang; Zhe Zhang
Journal:  Clin Rheumatol       Date:  2014-06-21       Impact factor: 2.980

4.  Association of single nucleotide polymorphisms in ADAM12 gene with susceptibility to knee osteoarthritis: a case-control study in a Chinese Han population.

Authors:  Suliang Lou; Zhifang Zhao; Jinqian Qian; Kefeng Zhao; Ran Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

Review 5.  Occupational and genetic risk factors for osteoarthritis: a review.

Authors:  Berran Yucesoy; Luenda E Charles; Brent Baker; Cecil M Burchfiel
Journal:  Work       Date:  2015-01-01

6.  Anticytokine therapy for osteoarthritis: evidence to date.

Authors:  Charles J Malemud
Journal:  Drugs Aging       Date:  2010-02-01       Impact factor: 3.923

7.  Genetics in osteoarthritis.

Authors:  Mercedes Fernández-Moreno; Ignacio Rego; Vanessa Carreira-Garcia; Francisco J Blanco
Journal:  Curr Genomics       Date:  2008-12       Impact factor: 2.236

8.  Common interleukin-6 promoter variants associate with the more severe forms of distal interphalangeal osteoarthritis.

Authors:  Olli-Pekka Kämäräinen; Svetlana Solovieva; Tapio Vehmas; Katariina Luoma; Hilkka Riihimäki; Leena Ala-Kokko; Minna Männikkö; Päivi Leino-Arjas
Journal:  Arthritis Res Ther       Date:  2008-02-08       Impact factor: 5.156

Review 9.  The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis.

Authors:  Piotr Wojdasiewicz; Łukasz A Poniatowski; Dariusz Szukiewicz
Journal:  Mediators Inflamm       Date:  2014-04-30       Impact factor: 4.711

Review 10.  Genetics in Cartilage Lesions: Basic Science and Therapy Approaches.

Authors:  Dawid Szwedowski; Joanna Szczepanek; Łukasz Paczesny; Przemysław Pękała; Jan Zabrzyński; Jacek Kruczyński
Journal:  Int J Mol Sci       Date:  2020-07-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.